- $89.16bn
- $143.30bn
- $402.07bn
Annual balance sheet for CVS Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 12,525 | 15,723 | 11,455 | 10,993 | 10,598 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 24,431 | 27,276 | 35,227 | 36,469 | 39,779 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 60,008 | 65,633 | 67,858 | 68,645 | 74,714 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 32,018 | 30,745 | 30,435 | 28,937 | 28,056 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 232,999 | 228,275 | 249,728 | 253,215 | 253,538 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 67,807 | 69,421 | 79,189 | 84,609 | 88,692 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 157,924 | 156,806 | 173,267 | 177,655 | 178,324 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 75,075 | 71,469 | 76,461 | 75,560 | 75,214 |
| Total Liabilities & Shareholders' Equity | 232,999 | 228,275 | 249,728 | 253,215 | 253,538 |
| Total Common Shares Outstanding |